Higher levels of neutralizing antibodies against KSHV in KS patients compared to asymptomatic individuals from Zambia.
Kaposi sarcoma-associated herpesvirus (KSHV) is the etiologic agent for Kaposi Sarcoma (KS), the most common cancer diagnosed in HIV- infected patients. The role of neutralizing antibodies in KS pathogenesis and in KSHV infected individuals is not clearly understood. The goal of this study was to in...
Main Authors: | Pankaj Kumar, Nithal Y Kuwa, Veenu Minhas, Clemence Marimo, Danielle M Shea, Chipepo Kankasa, Charles Wood |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3743886?pdf=render |
Similar Items
-
Antibody profiling and predictive modeling discriminate between Kaposi sarcoma and asymptomatic KSHV infection.
by: Sydney J Bennett, et al.
Published: (2024-02-01) -
Primary gamma-herpesviral infection in Zambian children
by: Mitchell Charles D, et al.
Published: (2010-05-01) -
Contraception and family planning among HIV-seroconcordant and -serodiscordant couples in the US and Zambia
by: Deborah L Jones, et al.
Published: (2010-05-01) -
Feasibility of using infant testing during immunization to estimate HIV mother-to-child-transmission rates in Zambia
by: Joseph Simbaya, et al.
Published: (2021-12-01) -
Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms
by: Thomas Fricke, et al.
Published: (2022-03-01)